• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Introduction to 5-(4-Fluoro-3-methoxyphenyl)-2-methoxyphenol (CAS No. 1261927-07-4)

5-(4-Fluoro-3-methoxyphenyl)-2-methoxyphenol, identified by its CAS number 1261927-07-4, is a significant compound in the field of pharmaceutical chemistry. This molecule has garnered attention due to its unique structural properties and potential applications in drug development. The presence of both fluoro and methoxy substituents in its aromatic ring system imparts distinct electronic and steric characteristics, making it a valuable candidate for further investigation.

The compound's structure consists of a benzene ring substituted at the 4-position with a fluoro group and at the 3-position with a methoxy group, while the 2-position is also occupied by a methoxy group. This specific arrangement of functional groups contributes to its reactivity and interaction with biological targets. The fluoro moiety, in particular, is well-known for its ability to modulate metabolic stability and binding affinity in drug molecules.

In recent years, there has been a growing interest in the development of novel pharmaceutical agents that incorporate fluorine atoms. The fluorine atom's ability to influence the electronic properties of a molecule can lead to enhanced binding to biological targets, improved pharmacokinetic profiles, and increased resistance to metabolic degradation. Consequently, compounds like 5-(4-Fluoro-3-methoxyphenyl)-2-methoxyphenol are being extensively studied for their potential therapeutic applications.

One of the most compelling aspects of this compound is its potential as a building block for more complex drug molecules. The methoxy groups provide additional sites for chemical modification, allowing chemists to tailor the properties of the compound for specific applications. For instance, they can be used to introduce polar functional groups or to enhance solubility in biological systems.

The pharmaceutical industry has shown particular interest in developing small molecule inhibitors targeting various enzymes and receptors involved in disease pathways. 5-(4-Fluoro-3-methoxyphenyl)-2-methoxyphenol, with its unique structural features, could serve as a key intermediate in the synthesis of such inhibitors. Its ability to interact with biological targets in a selective manner makes it an attractive candidate for further development.

Recent studies have highlighted the importance of fluorinated aromatic compounds in medicinal chemistry. These compounds have been shown to exhibit improved pharmacological properties compared to their non-fluorinated counterparts. For example, fluorinated phenols have demonstrated efficacy in treating neurological disorders, cardiovascular diseases, and cancer. The structural motif present in 5-(4-Fluoro-3-methoxyphenyl)-2-methoxyphenol aligns well with these trends and suggests that it may have similar therapeutic potential.

The synthesis of this compound involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, have been employed to construct the desired aromatic ring system efficiently. These methods ensure that the final product meets the stringent requirements for pharmaceutical applications.

In addition to its synthetic significance, 5-(4-Fluoro-3-methoxyphenyl)-2-methoxyphenol has been studied for its potential role in drug discovery programs. Researchers have explored its interactions with various biological targets using computational modeling and experimental techniques. These studies have provided valuable insights into its mechanism of action and have identified potential lead compounds for further optimization.

The compound's pharmacokinetic properties are also of great interest. Fluorinated aromatic compounds are known for their improved bioavailability and metabolic stability. By incorporating fluorine atoms into the molecular structure, it is possible to enhance these properties significantly. This could lead to more effective drug candidates with longer half-lives and reduced side effects.

Efforts are ongoing to develop new methodologies for the efficient synthesis and functionalization of fluorinated phenols like 5-(4-Fluoro-3-methoxyphenyl)-2-methoxyphenol. These advancements are crucial for enabling the rapid discovery and development of novel therapeutics. The ability to modify these compounds in a controlled manner will be key to unlocking their full potential in medicine.

The future prospects for this compound are promising, with ongoing research aimed at expanding its applications in drug development. Collaborative efforts between academia and industry are expected to drive innovation and lead to new breakthroughs. As our understanding of fluorinated aromatic compounds continues to grow, so too will their role in addressing some of the most challenging medical conditions.

• 64465-63-0(4-(4-Fluoro-3-methoxyphenyl)phenol)
• 1261897-59-9(2-fluoro-5-(4-fluoro-3-methoxyphenyl)phenol)
• 1261903-49-4(5-(3-Fluoro-4-hydroxyphenyl)-2-methoxyphenol)
• 1261896-72-3(4-(3-Fluorophenyl)-2-methoxyphenol)
• 1261957-92-9(3-(4-Fluoro-3-methoxyphenyl)phenol)
• 406482-61-9(2-fluoro-5-(4-methoxyphenyl)phenol)
• 1262001-85-3(2-fluoro-5-(3-methoxyphenyl)phenol)
• 1262002-53-8(2-fluoro-5-(3-fluoro-4-methoxyphenyl)phenol)
• 1261896-11-0(3-(3-Fluoro-4-methoxyphenyl)phenol)
• 1261890-90-7(5-(3,4-Dimethoxyphenyl)-2-fluorophenol)